Antimicrobials associated adverse drug reaction profiling: a four years retrospective study (Pharmacovigilance study)

References

• World Health Organization. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva, Switzerland: World Health Organization;. 2018.
   Google Scholar
• Nadeem M, Maqdoom M. A prospective study of antimicrobial utilization in post-operative care unit of a teaching hospital in South India. Int J Basic Clin Pharmacol. 2020 Jan;24(9):310–314.
   Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–70.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. Jama. 2005;294(10):1255–1259.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The importance of pharmacovigilance- Safety Monitoring of Medicinal Products.Geneva, Switzerland: World Health Organization; 2002.
   Google Scholar
• Shamna M, Dilip C, Ajmal M, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014;22(4):303–308.
   Web of Science ®Google Scholar
• Tamma PD, Avdic E, Li DX, et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315.
   PubMed Web of Science ®Google Scholar
• Jung IY, Kim JJ, Lee SJ, et al. Antibiotic-related adverse drug reactions at a Tertiary Care Hospital in South Korea. Biomed Res Int. 2017;2017:2017.
   Web of Science ®Google Scholar
• K Patel T, B Patel P. Incidence of adverse drug reactions in Indian hospitals: a systematic review of prospective studies. Curr Drug Saf. 2016;11(2):128–136.
   Web of Science ®Google Scholar
• Outterson K, Powers JH, Seoane‐Vazquez E, et al. Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980–2009. J Law Med Ethics. 2013;41(3):688–696.
   Web of Science ®Google Scholar
• World Health Organization. Pharmacovigilance: ensuring the safe use of medicines. Geneva, Switzerland: World Health Organization; 2004.
   Google Scholar
• Kalaiselvan V, Srivastava S, Singh A, et al. Pharmacovigilance in India: present scenario and future challenges. Drug Saf. 2019;42(3):339–346.
   Web of Science ®Google Scholar
• Kalaiselvan V, Thota P, Singh GN. Pharmacovigilance programme of India: recent developments and future perspectives. Indian J Pharmacol. 2016;48(6):624–628.
   Web of Science ®Google Scholar
• Singh P, Agrawal M, Hishikar R, et al. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: analysis of spontaneous reports during 1 year. Indian J Pharmacol. 2017;49(6):432–437.
   PubMed Web of Science ®Google Scholar
• Kumar A. Past, present and future of pharmacovigilance in India. Syst Rev Pharm. 2011;2(1):55–58.
   Google Scholar
• MedDRA M Introductory guide for Standardised MedDRA Queries (SMQs) Version 21.0. 2018.
   Google Scholar
• Behera SK, Das S, Xavier AS, et al. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018;40(4):903–910.
   PubMed Web of Science ®Google Scholar
• Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229–2232.
   PubMedGoogle Scholar
• Srinivasan R, Ramya G. Adverse drug reaction-causality assessment. Int J Res Pharm Chem. 2011;1(3):606–612.
   Google Scholar
• Kiguba R, Karamagi C, Bird SM. Antibiotic‐associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study. Pharmacol Res Perspect. 2017;5(2):e00298.
   Web of Science ®Google Scholar
• Hagiya H, Kokado R, Ueda A, et al. Association of adverse drug events with broad-spectrum antibiotic use in hospitalized patients: a single-center study. Intern Med. 2019;58(18):2621–2625.
   Web of Science ®Google Scholar
• Selva P. An analysis of adverse drug reactions reported in a Tertiary Care Hospital. Eur J Mol Clin Med. 2021;7(8):3601–3610.
   Google Scholar
• Shet A, Sundaresan S, Forsberg BC. Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector. Antimicrob Resist Infect Control. 2015;4(1):1–7.
   PubMedGoogle Scholar
• Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39–48.
   PubMedGoogle Scholar
• Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J. 1969;1(5643):536–539.
   Google Scholar
• Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol. 2001;2(6):349–351.
   PubMedGoogle Scholar
• Watson S, Caster O, Rochon PA, et al. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.
   PubMedGoogle Scholar
• Domecq C, Naranjo CA, Ruiz I, et al. Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol. 1980;18(8):362–366.
   PubMedGoogle Scholar
• Shehab N, Patel PR, Srinivasan A, et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–743.
   PubMed Web of Science ®Google Scholar
• Tandon VR, Sharma S, Khajuria V, et al. Adverse drug reactions profile of antimicrobials: a 3-year experience, from a tertiary care teaching hospital of India. Indian J Med Microbiol. 2015;33(3):393.
   Web of Science ®Google Scholar
• Sogn DD. Penicillin allergy. J Allergy Clin Immunol. 1984;74(4):589–593.
   Web of Science ®Google Scholar
• Atanasković‐Marković M, Veličković TĆ, Gavrović‐Jankulović M, et al. Immediate allergic reactions to cephalosporins and penicillins and their cross‐reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–347.
   PubMed Web of Science ®Google Scholar
• Bogas G, Mayorga C, Martín-Serrano Á, et al. Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes. Clin Transl Allergy. 2020;10(1):57.
   Web of Science ®Google Scholar
• Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: drug-induced hyperglycemia. Diabetes Spectr. 2011;24(4):234–238.
   Google Scholar
• Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–661.
   PubMed Web of Science ®Google Scholar
• Arulappen AL, Danial M, Sulaiman SAS. Evaluation of reported adverse drug reactions in antibiotic usage: a retrospective study from a tertiary care hospital, Malaysia. Front Pharmacol. 2018;9:809.
   Web of Science ®Google Scholar
• Moore N, Berdaï D, Blin P, et al. Pharmacovigilance–the next chapter. Therapies. 2019;74(6):557–567.
   PubMed Web of Science ®Google Scholar
• Sundaran S, Udayan A, Hareendranath K, et al. Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients. Pharmacy. 2018;6(4):108.
   Web of Science ®Google Scholar
• Shalviri G, Yousefian S, Gholami K. Adverse events induced by ceftriaxone: a 10‐year review of reported cases to Iranian Pharmacovigilance Centre. J Clin Pharm Ther. 2012;37(4):448–451.
   Web of Science ®Google Scholar
• Bandyopadhyay A, Chaurasia RC, Yadav RK, et al. A prospective study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital at Allahabad, Uttar Pradesh.
   Google Scholar
• Biset Ayalew M. Mortality and Its predictors among HIV infected patients taking antiretroviral treatment in Ethiopia: a systematic review. AIDS Res Treat. 2017;2017:2017.
   Web of Science ®Google Scholar
• Vinod KV, Arun K, Dutta TK. Dapsone hypersensitivity syndrome: a rare life threatening complication of dapsone therapy. J Pharmacol Pharmacother. 2013;4(2):158.
   PubMedGoogle Scholar
• Lorenz M, Wozel G, Schmitt J. Hypersensitivity reactions to dapsone: a systematic review. Acta Derm Venereol. 2012;92(2):194–199III.
   PubMed Web of Science ®Google Scholar